Eurofins-Cerep
ALECR | PA
Overview
Corporate Details
- ISIN(s):
- FR0004042232 (+3 more)
- LEI:
- 9695004C9D3ZX7FTZY16
- Country:
- France
- Address:
- 2 RUE DU PROFESSEUR GARGOUIL, 86600 CELLE-LEVESCAULT
- Website:
- https://www.eurofins.fr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Eurofins Scientific through its subsidiaries is the world leader in food, environment, pharmaceutical and cosmetic product testing, discovery pharmacology, forensics, advanced material sciences, and in agroscience Contract Research services. It is also one of the global independent market leaders in genomics and in the support of clinical studies, as well as in BioPharma Contract Development and Manufacturing. In addition, Eurofins is one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the USA. With 58,000 staff across a network of more than 1,000 independent companies in 54 countries and operating 900 laboratories, Eurofins offers a portfolio of over 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostics.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2019-04-29 00:00 |
Annual Report
rapport annuel 2018
|
French | 5.2 MB | |
| 2018-05-02 08:57 |
Annual Report
Rapport financier annuel 2017
|
French | 1.4 MB | |
| 2017-04-28 19:00 |
Annual / Quarterly Financial Statement
RAPPORT FINANCIER ANNUEL
|
French | 1.6 MB | |
| 2017-01-27 18:20 |
Share Issue/Capital Change
Eurofins-Cerep annonce la fin de la période de regroupement d'actions
|
French | 367.5 KB | |
| 2016-10-26 19:03 |
Interim Report
Rapport Financier Semestriel - 1er semestre 2016
|
French | 506.8 KB | |
| 2016-04-29 21:30 |
Annual Report
RAPPORT FINANCIER ANNUEL
|
French | 11.0 MB | |
| 2015-10-29 11:43 |
Interim Report
RAPPORT FINANCIER SEMESTRIEL - SEMESTRE CLOS LE 30 JUIN 2015
|
French | 557.7 KB | |
| 2015-10-28 19:00 |
Earnings Release
Eurofins-Cerep annonce ses résultats du 1er semestre 2015
|
French | 237.1 KB | |
| 2015-05-27 13:29 |
Management Discussion and Analysis
RAPPORT ANNUEL 2014
|
French | 1.5 MB | |
| 2015-01-14 15:00 |
Share Issue/Capital Change
Avis préalable à la mise en vente d'actions non réclamées
|
French | 193.4 KB | |
| 2015-01-14 14:21 |
Post-Annual General Meeting Information
Avis de regroupement d'actions (BALO du 17 décembre 2014 - Bulletin n° 151)
|
French | 120.4 KB | |
| 2014-04-30 16:15 |
Management Discussion and Analysis
Rapport Annuel 2013
|
French | 2.2 MB | |
| 2010-03-29 15:00 |
Earnings Release
2009 consolidated results / Positive EBITDA in the second half
|
English | 169.7 KB | |
| 2010-03-26 19:00 |
Earnings Release
Résultats consolidés 2009 : un EBE positif au second semestre
|
French | 181.8 KB | |
| 2010-03-19 08:00 |
Delisting Announcement
Introduction aujourdhui de Cerep sur Alternext
|
French | 110.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cuorips Inc. | Japan | 4894 | |
|
Cyfuse Biomedical K.K. | Japan | 4892 | |
|
DAIICHI SANKYO COMPANY, LIMITED | Japan | 4568 | |
|
Daito Pharmaceutical Co., Ltd. | Japan | 4577 | |
|
DanCann Pharma A/S | Denmark | DANCAN | |
|
DARWIN AG | Germany | 7V0 | |
|
Dechra Pharmaceuticals PLC | United Kingdom | DPH | |
|
Delta-Fly Pharma, Inc. | Japan | 4598 | |
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT |